DUBLIN--(BUSINESS WIRE)--For Graves’ Disease Awareness Month in July, Horizon Therapeutics plc (Nasdaq: HZNP) is teaming up with world-renowned track star and three-time Olympic gold medalist Gail ...
Given the abundance of months dedicated to diseases and ailments, July’s status as Graves’ Disease Awareness Month may not have registered with most Americans. Horizon Therapeutics is nonetheless ...
– Campaign helps people know their risks and identify the signs and symptoms of TED to encourage early diagnosis and management – “My journey to diagnosis with Thyroid Eye Disease was long and ...
DUBLIN--(BUSINESS WIRE)--To commemorate Graves’ Disease Awareness Month this July, Horizon Therapeutics plc (Nasdaq: HZNP) is teaming up with all-star patient advocates, Wanda Durant and Gail Devers, ...
AtLANTA - Three-time Olympic Gold Medalist Gail Devers often says her biggest opponent wasn’t any of the racers on the track, but a hidden disease she struggled with. FOX 5 caught up with Devers as ...
Living with a rare disease can often mean days upon months upon years of searching for answers. Unfortunately, this is the case for many who are living with Thyroid Eye Disease (TED) – a rare ...
Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (BPT) – LaQuilla Harris, a devoted mother, grandmother and ...
Vyvgart, an FcRn inhibitor already approved for generalized myasthenia gravis, is also being tested in myositis, Sjögren’s disease and the “clinically related” Graves disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback